June 3rd: Personalized Therapy Benefits Late-Stage Cancer Patients in Clinical Trial - Cancerwise | Cancer blog from MD Anderson Cancer Center

"Researchers analyzed tumors of 1,144 patients with metastatic or inoperable cancer. Their median age was 58, and the median number of prior treatments was four. Of these, 460 had one or more gene defects targetable by available approved or experimental drugs."